159 related articles for article (PubMed ID: 12813173)
1. Vitamin D2 analog 19-nor-1,25-dihydroxyvitamin D2: antitumor activity against leukemia, myeloma, and colon cancer cells.
Kumagai T; O'Kelly J; Said JW; Koeffler HP
J Natl Cancer Inst; 2003 Jun; 95(12):896-905. PubMed ID: 12813173
[TBL] [Abstract][Full Text] [Related]
2. 19-nor-1alpha,25-dihydroxyvitamin D(2) (paricalcitol): effects on clonal proliferation, differentiation, and apoptosis in human leukemic cell lines.
Molnár I; Kute T; Willingham MC; Powell BL; Dodge WH; Schwartz GG
J Cancer Res Clin Oncol; 2003 Jan; 129(1):35-42. PubMed ID: 12618899
[TBL] [Abstract][Full Text] [Related]
3. Suppressive effect of 19-nor-1α-25-dihydroxyvitamin D2 on gastric cancer cells and peritoneal metastasis model.
Park MR; Lee JH; Park MS; Hwang JE; Shim HJ; Cho SH; Chung IJ; Bae WK
J Korean Med Sci; 2012 Sep; 27(9):1037-43. PubMed ID: 22969249
[TBL] [Abstract][Full Text] [Related]
4. Antitumor effects of two less-calcemic vitamin D analogs (Paricalcitol and QW-1624F2-2) in squamous cell carcinoma cells.
Alagbala AA; Johnson CS; Trump DL; Posner GH; Foster BA
Oncology; 2006; 70(6):483-92. PubMed ID: 17237623
[TBL] [Abstract][Full Text] [Related]
5. 19-Nor-1alpha,25-dihydroxyvitamin D2 (paricalcitol) exerts anticancer activity against HL-60 cells in vitro at clinically achievable concentrations.
Molnár I; Kute T; Willingham MC; Schwartz GG
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):539-43. PubMed ID: 15225834
[TBL] [Abstract][Full Text] [Related]
6. Dimethyl fumarate and vitamin D derivatives cooperatively enhance VDR and Nrf2 signaling in differentiating AML cells in vitro and inhibit leukemia progression in a xenograft mouse model.
Nachliely M; Trachtenberg A; Khalfin B; Nalbandyan K; Cohen-Lahav M; Yasuda K; Sakaki T; Kutner A; Danilenko M
J Steroid Biochem Mol Biol; 2019 Apr; 188():8-16. PubMed ID: 30508646
[TBL] [Abstract][Full Text] [Related]
7. 19-Nor-1,25(OH)2D2 (a novel, noncalcemic vitamin D analogue), combined with arsenic trioxide, has potent antitumor activity against myeloid leukemia.
Kumagai T; Shih LY; Hughes SV; Desmond JC; O'Kelly J; Hewison M; Koeffler HP
Cancer Res; 2005 Mar; 65(6):2488-97. PubMed ID: 15781666
[TBL] [Abstract][Full Text] [Related]
8. 19-nor-1 alpha,25-dihydroxyvitamin D2 (paricalcitol) inhibits the proliferation of human pancreatic cancer cells in vitro and in vivo.
Schwartz GG; Eads D; Naczki C; Northrup S; Chen T; Koumenis C
Cancer Biol Ther; 2008 Mar; 7(3):430-6. PubMed ID: 18094617
[TBL] [Abstract][Full Text] [Related]
9. Paricalcitol, a vitamin d receptor activator, inhibits tumor formation in a murine model of uterine fibroids.
Halder SK; Sharan C; Al-Hendy O; Al-Hendy A
Reprod Sci; 2014 Sep; 21(9):1108-19. PubMed ID: 24925855
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of a non-hypercalcemic vitamin-D2 derived anti-cancer agent (MT19c) and inhibition of fatty acid synthesis in an ovarian cancer xenograft model.
Moore RG; Lange TS; Robinson K; Kim KK; Uzun A; Horan TC; Kawar N; Yano N; Chu SR; Mao Q; Brard L; DePaepe ME; Padbury JF; Arnold LA; Brodsky A; Shen TL; Singh RK
PLoS One; 2012; 7(4):e34443. PubMed ID: 22509304
[TBL] [Abstract][Full Text] [Related]
11. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
[TBL] [Abstract][Full Text] [Related]
12. 1,24(S)-dihydroxyvitamin D2, an endogenous vitamin D2 metabolite, inhibits growth of breast cancer cells and tumors.
Zinser GM; Tribble E; Valrance M; Urben CM; Knutson JC; Mazess RB; Strugnell SA; Welsh J
Anticancer Res; 2005; 25(1A):235-41. PubMed ID: 15816543
[TBL] [Abstract][Full Text] [Related]
13. Paricalcitol (19-nor-1,25-dihydroxyvitamin D2) and calcitriol (1,25-dihydroxyvitamin D3) exert potent immunomodulatory effects on dendritic cells and inhibit induction of antigen-specific T cells.
Sochorová K; Budinský V; Rozková D; Tobiasová Z; Dusilová-Sulková S; Spísek R; Bartůnková J
Clin Immunol; 2009 Oct; 133(1):69-77. PubMed ID: 19660988
[TBL] [Abstract][Full Text] [Related]
14. Characterization of mammary tumor cell lines from wild type and vitamin D3 receptor knockout mice.
Zinser GM; McEleney K; Welsh J
Mol Cell Endocrinol; 2003 Feb; 200(1-2):67-80. PubMed ID: 12644300
[TBL] [Abstract][Full Text] [Related]
15. The effects of 1alpha,24(S)-dihydroxyvitamin D(2) analog on cancer cell proliferation and cytokine expression.
Shany S; Levy Y; Lahav-Cohen M
Steroids; 2001; 66(3-5):319-25. PubMed ID: 11179740
[TBL] [Abstract][Full Text] [Related]
16. Novel analogs of 1,25-dihydroxyvitamin D
Nachliely M; Sharony E; Kutner A; Danilenko M
J Steroid Biochem Mol Biol; 2016 Nov; 164():59-65. PubMed ID: 26365556
[TBL] [Abstract][Full Text] [Related]
17. Cell cycle arrest induced by the vitamin D(3) analog EB1089 in NCI-H929 myeloma cells is associated with induction of the cyclin-dependent kinase inhibitor p27.
Park WH; Seol JG; Kim ES; Jung CW; Lee CC; Binderup L; Koeffler HP; Kim BK; Lee YY
Exp Cell Res; 2000 Feb; 254(2):279-86. PubMed ID: 10640426
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the first Ergocalciferol-derived, non hypercalcemic anti-cancer agent MT19c in ovarian cancer SKOV-3 cell lines.
Brard L; Lange TS; Robison K; Kim KK; Ara T; McCallum MM; Arnold LA; Moore RG; Singh RK
Gynecol Oncol; 2011 Nov; 123(2):370-8. PubMed ID: 21803404
[TBL] [Abstract][Full Text] [Related]
19. Activation of vitamin D receptor attenuates high glucose-induced cellular injury partially dependent on CYP2J5 in murine renal tubule epithelial cell.
Liu Y; Li L; Yi B; Hu ZX; Li AM; Yang C; Zheng L; Zhang H
Life Sci; 2019 Oct; 234():116755. PubMed ID: 31415769
[TBL] [Abstract][Full Text] [Related]
20. Biological evaluation of new vitamin D
Corcoran A; Bermudez MA; Seoane S; Perez-Fernandez R; Krupa M; Pietraszek A; Chodyński M; Kutner A; Brown G; Marcinkowska E
J Steroid Biochem Mol Biol; 2016 Nov; 164():66-71. PubMed ID: 26429396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
